Assessment of drug adherence and knowledge about the disease of patients with type 2 diabetes during inpatient admission to a diabetes clinic within the Rhine-Main regio

• Conditions: Type 2 diabetes mellitus; E11

• Registration Number: DRKS00015850
• Lead Sponsor: Chefarzt Abteilung Endokrinologie und Diabetologie Krankenhaus Sachsenhausen

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-04-24
• Study Completion: 2019-08-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age: >= 18 years,
prescription of at least three medicaments, including at least one oral antidiabetic or Insulin,
HbA1c level at admission >= 6.5% or admission caused by hypoglycaemia,
ability to consent,
ability to understand spoken and written German

Exclusion Criteria

New onset type 2 diabetes,
Type 1 Diabetes,
pregnancy,
homecare patients,
transfer of the patient to another ward,
In case of diagnosis of severe comorbidities, which would significantly reduce life expectancy or require extensive systemic treatment

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Drug adherence and patient knowledge about the diabetes disease <br>Evaluation based on a structured questionnaire. The questionnaire on drug adherence is based on the adherence barriers questionnaire. The questionnaire on patient knowledge is based on the Michigan Diabetes knowledge test. The patient will be interviewed during the inpatient stay.

Secondary Outcome Measures

Name	Time	Method
Blood sugar levels: HbA1c value and fasting blood sugar at inpatient admission